September 2015: This quality standard has been updated to ensure alignment with the NICE quality standard for NICE's quality standard for cardiovascular disease and lipid modification published in September 2015.
Statement 3 on statin therapy has been removed and replaced by statements in the quality standard for cardiovascular disease and lipid modification that cover primary and secondary prevention of cardiovascular disease.
Minor changes since publication
August 2019: Changes have been made to align this quality standard with the updated NICE guideline on hypertension in adults. Links, definitions and source guidance references have been updated throughout.